PLX-R18 (avoplacel), a placental expanded mesenchymal-like stromal cell therapy shows favorable safety and appears to improve incomplete hematopoietic recovery after hematopoietic cell transplantation (HCT) Meeting Abstract


Authors: Lazarus, H. M.; McGuirk, J. P.; Zuckerman, T.; Metheny, L.; Pineiro, L.; Litzow, M. R.; Rowley, S. D.; Avni, B.; Tamari, R.; Sheleg, M.; Rothenstein, D.; Halevy, N.; Rowe, J. M.
Abstract Title: PLX-R18 (avoplacel), a placental expanded mesenchymal-like stromal cell therapy shows favorable safety and appears to improve incomplete hematopoietic recovery after hematopoietic cell transplantation (HCT)
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 10447
End Page: 10448
Language: English
ACCESSION: WOS:000893230303198
DOI: 10.1182/blood-2022-169266
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Roni Tamari
    208 Tamari
Related MSK Work